Figure 5.
Size distribution of DA-ss-DT (A) and DA-cc-DT (B) in response to GSH determined by DLS measurement. Reduction-triggered release of DOX (C) and TRI (D) from DA-ss-DT and DA-cc-DT nanoparticles in PBS (pH 7.4) with 10 µM GSH. Data are represented as mean±SD (n=3).
Abbreviations: DOX, doxorubicin; DLS, dynamic light scattering; GSH, glutathione; TRI, triptolide.